Archives: Agenda

• Current biotech funding and pipeline trends shaping early and late phase development
• How market dynamics are influencing trial initiation and program design in 2025
• Shifts in CRO selection and strategic approaches among emerging biotechs

• Discuss methods for identifying and engaging the right patient population
• Learn strategies for reducing barriers to participation
• Focus on enhancing site and investigator engagement training, tools, and incentives
• Building trust – communication and transparency takeaways

• Includes clear, relatable examples of how AI is practically applied within healthcare and pharma, empowering executives without deep technical backgrounds

• Emerging Industry trends
• Macroeconomic trends
• Technology trends
• Funding trends

• A Smarter, Leaner Approach, Decentralized, and AI-Driven Trials, Built to Cut Complexity and Accelerate Outcomes

Kick things off with the big idea, Milo EDC is built for smarter, faster, and more modern clinical trials.

• The Hidden Costs of Complex eCRF Systems

Highlight how traditional platforms slow things down, cost more, and require specialized roles and training just to function.

• Introduce Milo EDC – Built for the Future

Show how Milo simplifies everything with a unified platform, automation, and patient-first features.

• Market Segments Where Milo Excels

Walk through the key trial types where Milo really shines, from device studies to global CRO deployments.

• Case Study,  Diabetic foot ulcer Trial

Share a real-world example of how Milo helped a sponsor hit enrollment goals early and stay compliant.

• Strategic Advantages for Stakeholders

Break down Milo’s benefits in a quick comparisons: speed, engagement, compliance, and cost.

• Closing & Q&A

Wrap up with a clear message: Milo isn’t just another tool, it’s a strategic enabler for modern trials.